参考文献/References:
[1] Anandan C,Khuder SA,Koffman BM.Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barre syndrome[J].Muscle Nerve,2017,56(2):331-333.
[2] Nagappa M,Rahul W,Sinha S,et al.Guillain Barre syndrome in the elderly:Experience from a tertiary-care hospital in India[J].J Clin Neurosci,2017,46:45-49.
[3] Colls BM.Guillain-Barre syndrome and hyponatraemia[J].Intern Med J,2003,33(1-2):5-9.
[4] Rumalla K,Reddy AY,Letchuman V,et al.Hyponatremia in Guillain-Barre syndrome[J].J Clin Neuromuscul Dis,2017,18(4):207-217.
[5] James J.Syndrome of inappropriate secretion of antidiuretic hormone preceding Guillain-Barré syndrome[J].Journal of Clinical and Diagnostic Research,2017,11(9):OD16-OD17.
[6] Wang Y,Liu J.Hyponatremia is a predictor for poor outcome in Guillain-Barre syndrome[J].Neurol Res,2015,37(4):347-351.
[7] Hiew FL,Winer JB,Rajabally YA.Hyponatraemia in Guillain-Barre syndrome revisited[J].Acta Neurol Scand,2016,133(4):295-301.
[8] Smith D,Moore K,Tormey W,et al.Downward resetting of the osmotic threshold for thirst in patients with SIADH[J].Am J Physiol Endocrinol Metab,2004,287(5):E1019-E1023.
[9] Tzamaloukas AH,Malhotra D,Rosen BH,et al.Principles of management of severe hyponatremia[J].J Am Heart Assoc,2013,2(1):e5199.
[10] Mastorakos G,Weber JS,Magiakou MA,et al.Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion[J].J Clin Endocrinol Metab,1994,79(4):934-939.
[11] Press R,Ozenci V,Kouwenhoven M,et al.Non-T(H)1 cytokines are augmented systematically early in Guillain-Barre syndrome[J].Neurology,2002,8(3):476-478.
[12] Maimone D,Annunziata P,Simone IL,et al.Interleukin-6 levels in the cerebrospinal-fluid and serum of patients with guillain-barre-syndrome and chronic inflammatory demyelinating polyradiculoneuropathy[J].Journal of Neuroimmunology,1993,47(1):55-62.
[13] Swart RM,Hoorn EJ,Betjes MG,et al.Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation[J].Nephron Physiol,2011,118(2):45-51.
[14] Tenny S,Thorell W.Cerebral salt wasting syndrome.In:Statpearls[Internet].Treasure Island(FL):Statpearls Publishing,2020.Available from:http:∥www.ncbi.n1m.nih.gov/books/NBK5438551.
[15] Arieff A I,Gabbai R,Goldfine ID.Cerebral salt-wasting syndrome:Diagnosis by urine sodium excretion[J].Am J Med Sci,2017,354(4):350-354.
[16] Harshal D,Ann C,CR,et al.Cerebral salt wasting syndrome[J].Journal of Neuroanaesthesiology & Critical Care,2016,3(3):205-210.
[17] Schwartz W B,Bennett W,Curelop S,et al.A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone[J].Am J Med,1957,23(4):529-542.
[18] Maesaka JK,Imbriano LJ,Ali NM,et al.Is it cerebral or renal salt wasting?[J].Kidney Int,2009,76(9):934-938.
[19] Maesaka JK,Imbriano LJ,Miyawaki N.Determining fractional urate excretion rates in hyponatremic conditions and improved methods to distinguish cerebral/renal salt wasting from the syndrome of inappropriate secretion of antidiuretic hormone[J].Front Med(Lausanne),2018,5:319.
[20] Katayama Y,Haraoka J,Hirabayashi H,et al.A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage[J].Stroke,2007,38(8):2373-2375.
[21] Sherlock M,Thompson CJ.The syndrome of inappropriate antidiuretic hormone: current and future management options[J].Eur J Endocrinol,2010,162(Suppl 1):S13-S18.
[22] Esposito P,Piotti G,Bianzina S,et al.The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options[J].Nephron Clin Pract,2011,119(1):c62-c73,c73.
[23] Sterns RH,Riggs JE,Schochet SJ.Osmotic demyelination syndrome following correction of hyponatremia[J].N Engl J Med,1986,314(24):1535-1542.
[24] Decaux G.SIADH and vaptans[J].Ann Endocrinol(Paris),2012,73(2):130-134.
[25] Costello-Boerrigter LC,Boerrigter G,Burnett JJ.Pharmacology of vasopressin antagonists[J].Heart Fail Rev,2009,14(2):75-82.
[26] Sipila JO,Kauko T,Soilu-Hanninen M.Admission sodium level and prognosis in adult Guillain-Barre syndrome[J].Int J Neurosci,2017,127(4):344-349.